Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Market sentiment signals for CRISPR Therapeutics (CRSP): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
30 analysts
Options Flow (P/C)
—
Avg Consensus PT
$72
+77.7%
Highest Price Target
$120
+197.2%
Lowest Price Target
$32
-20.7%
Short Interest
20.4%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Citigroup | Yigal Nochomovitz— | +122.9% | $88 → $90 | Maintained | Buy |
| Nov 4, 2026 | Wells Fargo | Yanan Zhu— | +73.4% | $75 → $70 | Maintained | Equal-Weight |
